Clinicians should ask patients if they have experienced episodes of overeating with a loss of control over eating within the past 4 weeks
At the Institute of Endocrinology and Metabolism in Kiev, Ukraine, 104 patients with GD, aged between 42 and 45 years, were examined for the level of selenium in the serum, the median urinary iodine excretion, relationship between selenium and ioduria levels [64]
Graphical abstract Similar content being viewed by others Introduction Over the past decade, glucagon-like peptide-1 receptor agonists (GLP-1RAs) have demonstrated cardiovascular, renal, and metabolic benefits in patients with type 2 diabetes (T2D) and atherosclerotic cardiovascular disease (ASCVD) or high cardiovascular (CV) risk, and have subsequently been incorporated into multiple international guidelines [1,2,3]
Furthermore, to the best of our knowledge, no head-to-head studies investigating the risks of major and mild CI have been conducted between DPP-4i and GLP-1a using real-world data